<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">The response to virus-induced tissue damage could result in respiratory failure with acute respiratory distress syndrome (ARDS), characterized by rapid onset of widespread inflammation in the lungs [
 <xref ref-type="bibr" rid="CR11">11</xref>]. Numerous studies have shown that pro-inflammatory cytokine levels are extremely high in subjects with severe/critical COVID-19. Cytokine storm syndrome (CSS) seems to be of particular concern in patients with severe or critical conditions of infection. COVID-19 patients have high levels of pro-inflammatory cytokines in lung; thus, blocking circulating IL-6, IL-1, and TNF could be effective for patients in respiratory insufficiency by COVID-19 [
 <xref ref-type="bibr" rid="CR12">12</xref>].
</p>
